These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12100371)

  • 21. Comparison of gel permeation chromatography, density gradient ultracentrifugation and precipitation methods for quantitation of very-low-, low- and high-density lipoprotein cholesterol.
    Nyyssönen K; Salonen JT
    J Chromatogr; 1991 Oct; 570(2):382-9. PubMed ID: 1797853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The lipoprotein fraction between VLDL and LDL detected by biphasic agarose gel electrophoresis reflects serum remnant lipoprotein and Lp(a) concentrations.
    Sato I; Taniguchi T; Ishikawa Y; Kusuki M; Hayashi F; Mukai M; Kawano S; Kondo S; Yamashita S; Kumagai S
    J Atheroscler Thromb; 2006 Feb; 13(1):55-61. PubMed ID: 16505592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study.
    Browne RW; Weinstock-Guttman B; Zivadinov R; Horakova D; Bodziak ML; Tamaño-Blanco M; Badgett D; Tyblova M; Vaneckova M; Seidl Z; Krasensky J; Bergsland N; Ramasamy DP; Hagemeier J; Qu J; Havrdova E; Ramanathan M
    J Steroid Biochem Mol Biol; 2014 Sep; 143():424-33. PubMed ID: 24950029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.
    Zhornitsky S; McKay KA; Metz LM; Teunissen CE; Rangachari M
    Mult Scler Relat Disord; 2016 Jan; 5():53-65. PubMed ID: 26856944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma lipoprotein lipids in relation to the MspI polymorphism of the apolipoprotein AII gene in Caucasian men. Lack of association with plasma triglyceride concentration.
    Rajput-Williams J; Eyre J; Nanjee MN; Crook D; Scott J; Miller NE
    Atherosclerosis; 1989 May; 77(1):31-6. PubMed ID: 2566309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma vitamin E, apolipoprotein B and HDL-cholesterol in middle-aged men from southern Italy.
    Rubba P; Mancini M; Fidanza F; Leccia G; Riemersma RA; Gey KF
    Atherosclerosis; 1989 May; 77(1):25-9. PubMed ID: 2719759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death.
    Takeichi S; Yukawa N; Nakajima Y; Osawa M; Saito T; Seto Y; Nakano T; Saniabadi AR; Adachi M; Wang T; Nakajima K
    Atherosclerosis; 1999 Feb; 142(2):309-15. PubMed ID: 10030382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
    Sacks FM; Alaupovic P; Moye LA; Cole TG; Sussex B; Stampfer MJ; Pfeffer MA; Braunwald E
    Circulation; 2000 Oct; 102(16):1886-92. PubMed ID: 11034934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMR analysis of lipoprotein particle size does not increase sensitivity to the effect of soy protein on CVD risk when compared with the traditional lipid profile.
    Santo AS; Cunningham AM; Alhassan S; Browne RW; Burton H; Leddy JJ; Grandjean PW; Horvath SM; Horvath PJ
    Appl Physiol Nutr Metab; 2008 Jun; 33(3):489-500. PubMed ID: 18461102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study on serum triglyceride and lipoproteins cholesterol in coronary heart disease patients.
    Awan ZA; Baseer A
    J Pak Med Assoc; 1995 Oct; 45(10):263-6. PubMed ID: 8714621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis.
    Weinstock-Guttman B; Zivadinov R; Mahfooz N; Carl E; Drake A; Schneider J; Teter B; Hussein S; Mehta B; Weiskopf M; Durfee J; Bergsland N; Ramanathan M
    J Neuroinflammation; 2011 Oct; 8():127. PubMed ID: 21970791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A palm oil-rich diet may reduce serum lipids in healthy young individuals.
    Ladeia AM; Costa-Matos E; Barata-Passos R; Costa Guimarães A
    Nutrition; 2008 Jan; 24(1):11-5. PubMed ID: 17884342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of fitness status on very-low-density lipoprotein subfractions and lipoprotein(a) in men and women.
    Thomas TR; Ziogas G; Harris WS
    Metabolism; 1997 Oct; 46(10):1178-83. PubMed ID: 9322803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in plasma total and lipoprotein cholesterol during incubation of whole blood samples at 37 degrees C--influence of LCAT inhibitors.
    Rühling K; Lang A; Holtz H; Winkler L; Schlag B; Till U
    Clin Chim Acta; 1992 Feb; 205(3):205-12. PubMed ID: 1576746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasma triglycerides, cholesterol and apolipoprotein E during prolonged fasting in normal subjects.
    Markel A; Brook JG; Aviram M
    Postgrad Med J; 1985 May; 61(715):395-400. PubMed ID: 4022874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.